Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia Cohort | Zendy

Jomy George | Zendy; Safia Kuriakose | Zendy; Anne K. Monroe | Zendy; Qingjiang Hou | Zendy; Morgan Byrne | Zendy; Alice K. Pau | Zendy; Henry Masur | Zendy; Colleen Hadigan | Zendy; Amanda D. Castel | Zendy; Michael A. Horberg | Zendy; Jeffery Binkley | Zendy; Rob Taylor | Zendy; Nabil Rayeed | Zendy; Cheryl Akridge | Zendy; Stacey Purinton | Zendy; Jeff Naughton | Zendy; David B. Parfitt | Zendy; Lawrence J. D’Angelo | Zendy; Natella Rahkmanina | Zendy; Michael Kharfen | Zendy; Michael Serlin | Zendy; Princy Kumar | Zendy; David M. Parenti | Zendy; Alan E. Greenberg | Zendy; Lindsey Powers Happ | Zendy; Maria Jaurretche | Zendy; Brittany Wilbourn | Zendy; James A. Peterson | Zendy; Matthew E. Levy | Zendy; Yan Ma | Zendy; Ronald D Wilcox | Zendy; Sohail Rana | Zendy; Ricardo Fernández | Zendy; Annick Hebou | Zendy; Carl W. Dieffenbach | Zendy; José Bordón | Zendy; Gebeyehu Teferi | Zendy; Debra Benator | Zendy; Marı́a Elena Ruiz | Zendy; Deborah Goldstein | Zendy

Open Access

Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia Cohort

Author(s) -

Jomy George,

Safia Kuriakose,

Anne K. Monroe,

Qingjiang Hou,

Morgan Byrne,

Alice K. Pau,

Henry Masur,

Colleen Hadigan,

Amanda D. Castel,

Michael A. Horberg,

Jeffery Binkley,

Rob Taylor,

Nabil Rayeed,

Cheryl Akridge,

Stacey Purinton,

Jeff Naughton,

David B. Parfitt,

Lawrence J. D’Angelo,

Natella Rahkmanina,

Michael Kharfen,

Michael Serlin,

Princy Kumar,

David M. Parenti,

Alan E. Greenberg,

Lindsey Powers Happ,

Maria Jaurretche,

Brittany Wilbourn,

James A. Peterson,

Matthew E. Levy,

Yan Ma,

Ronald D Wilcox,

Sohail Rana,

Ricardo Fernández,

Annick Hebou,

Carl W. Dieffenbach,

José Bordón,

Gebeyehu Teferi,

Debra Benator,

Marı́a Elena Ruiz,

Deborah Goldstein

Publication year - 2020

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciaa284

Subject(s) - medicine , rivaroxaban , cohort , anticoagulant , warfarin , medical prescription , pediatrics , pharmacology , atrial fibrillation

Direct oral anticoagulants (DOACs) have become first-line treatment for venous thrombotic events. DOAC prescribing trends among people living with human immunodeficiency virus (PWH) are not well described. The coadministration of DOACs with the antiretroviral (ARV) pharmacokinetic boosters ritonavir (RTV) or cobicistat (COBI) may be complicated by pharmacokinetic interactions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research